Q2 2022 · 13F-HR
Antipodean Advisors LLCholdings as filed
Filed 2022-08-15 · accession 0000919574-22-004845
$61,391
Reported value
9
Positions
2022-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 81141R100 | SE | SEA LTD | $23,401 | 38.1% | 350,000 | Common | SOLE |
| 14161W105 | CDLX | CARDLYTICS INC | $14,252 | 23.2% | 638,800 | Common | SOLE |
| 146869102 | CVNA | CARVANA CO | $9,145 | 14.9% | 405,000 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $7,790 | 12.7% | 1,000,000 | Common | SOLE |
| 464287184 | FXI | ISHARES TR | $1,696 | 2.76% | 50,000 | Common | SOLE |
| 92189F106 | GDX | VANECK ETF TRUST | $1,643 | 2.68% | 60,000 | Common | SOLE |
| 500767306 | KWEB | KRANESHARES TR | $1,638 | 2.67% | 50,000 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $1,543 | 2.51% | 425,000 | Common | SOLE |
| 92189F403 | — | VANECK ETF TRUST | $283 | 0.46% | 50,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.